ALMAC - active and placebo capsule manufacture for the LAMDARCT Clinical Trial
- Belfast Health and Social Care Trust
- Northern Ireland
- Direct award
- 1 November 2025 to 1 November 2029
Manufacturing of active and placebo capsules specifically for the LAMDARCT clinical trial. This contract involves the technical production and supply of pharmaceutical materials required to support the trial's research objectives over a four-year period.
- Awarded value
- £417k
- As published
- Published
- 11 August 2025
- Contract length
- 48 months
- Ends 1 November 2029